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ABSTRACT
Background: Epinastine hydrochloride (epinastine) is a second-generation histamine H1-receptor antagonist
widely used as an anti-allergic and anti-pruritic. To explore possible new aspects of the anti-pruritic mechanism
of epinastine, in particular any effects on the peripheral nervous system, we examined epinastine’s effects on
sensory neurons using cultured murine dorsal root ganglion (DRG).
Methods: We performed a quantitative assessment of neurite growth and substance P (SP) release from iso-
lated DRG in the presence versus the absence of epinastine. Mechanism(s) of epinastine’s effects on sensory
neurons were detected by examining its neurotoxicity, inhibitory action on nerve growth factor (NGF), and
modulatory function on NGF receptors.
Results: The percentage of DRG with outgrowing neurites, total number of neurites, and average extension
length of neurites were decreased by epinastine in a concentration-dependent manner. Epinastine did not ex-
hibit any evidence of neurotoxicity on sensory neurons, degradation and inactivation ability on NGF, or effects
on expression of NGF receptors. Also, no effects on neural progenitor cells of the central nervous system in
culture were observed. Epinastine suppressed capsaicin-induced SP release from DRG neurons in a dose-
dependent fashion.
Conclusions: The results demonstrate that epinastine has inhibitory effects on sensory neuronal growth,
which may explain its clinical effects including potent anti-pruritic activity.
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INTRODUCTION
Histamine H1-receptor antagonists (antihistamines)
are anti-allergic drugs used extensively for the man-
agement of various histamine-related allergic disor-
ders such as atopic dermatitis, urticaria, and allergic
rhinitis.1 Mast cells are rich sources of many distinct
biologically active multifunctional mediators includ-
ing histamine, prostaglandins, leukotrienes, neutral
proteases, cytokines, and neurogenic factors.2 Hista-
mine is a fundamental mediator released from tissue
mast cells during the immediate allergic response1
and chiefly from recruited basophils during the late-
phase response. 3 Histamine interacts with H1-
receptors to induce smooth muscle contraction, en-
hanced capillary permeability, and neuronal stimula-
tion with multiple secondary effects resulting in in-
duction of neurogenic inflammation and onset of itch
sensation in the skin.4 Antihistamines are hence the
first-choice drugs for the treatment of cutaneous pru-
ritic diseases such as atopic dermatitis in which mast
cells and released histamine play significant roles.5
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Afferent somatic nerves with fine unmyelinated C-
fibers derive from dorsal root ganglia (DRG) and in-
nervate the skin. C-fibers can be activated by a wide
range of physical and chemical stimuli , resulting in
reception of cutaneous sensations such as itching, by
intervention of the central nervous system.6 Neuro-
genic components are involved in the pathogenesis
and onset of itch sensation of a variety of cutaneous
inflammatory diseases via the neuroimmunocutane-
ous system.7 Increased attention has been directed
towards interactions between components of the
nervous system and multiple target cells of the im-
mune system. Communication between nerves and
mast cells is a prototypic demonstration of such
neuroimmune interactions. Recent evidence suggests
that substance P (SP), a neuropeptide belonging to
the tachykinin family, is an important mediator in inti-
mate nerve-mast cell cross-talk.8 There is also consid-
erable evidence suggesting that the nervous system
can influence the course of diseases through emo-
tional stress, altered patterns of cutaneous innerva-
tion, and abnormal expression and increased levels of
neuropeptide and neurotrophic factors such as SP
and nerve growth factor (NGF) both in the lesional
skin and peripheral blood.7,9-11
Epinastine hydrochloride (epinastine) is a nonse-
dative, second-generation histamine H1-receptor an-
tagonist commonly used in Japan with good clinical
results.12 In the dermatological field, epinastine has
been shown to have clinically potent and long-lasting
anti-pruritic effects with infrequent adverse reactions
in patients even with a generalized, severe degree of
pruritus such as in atopic dermatitis. Epinastine pos-
sesses inhibitory action on not only the H1-receptor
but also on inflammatory mediator release from mast
cells.13,14 In addition to these common antihistamine
activities, epinastine exerts a variety of unique phar-
macological modes of action including modulating in-
terleukin ( IL ) -4 mRNA expression by peripheral
blood mononuclear cells , 15 inhibiting IL-8 release
from eosinophils,16 and preventing superoxide gen-
eration by neutrophils.17 To explore possible new as-
pects of epinastine’s anti-pruritic mechanisms, espe-
cially direct effects on the peripheral nervous system,
we examined its effects on sensory neurons using
cultured murine DRG in vitro.
METHODS
ANIMALS AND DISSECTION OF DRG
ICR mice (Japan SLC, Shizuoka, Japan) of postnatal
day 1 were used in the study. The experimental pro-
cedures for mice were conducted in accordance with
the guidelines of the Guiding Principles for the Care
and Use of Laboratory Animals approved by the Com-
mittee for Animal Experiments in Toyama Medical
and Pharmaceutical University. All mice were anes-
thetized with an ip injection of 6 mg Na-
pentobarbital100 g body weight. DRG from L1 to L6
were dissected and mice subsequently euthanized by
CO2 asphyxiation.
DRG CULTURE
DRG were desheathed in ice-cold DMEM (Gibco
BRL, Carlsbad, CA, USA) supplemented with 2 mM
L-glutamine, 1 mM sodium pyruvate , 1% penicillin ,
streptomycin, Fungizone antibiotic solution (Sigma,
St. Louis, MO, USA), and 10% heat-inactivated fetal
bovine serum (Bioserum, Canterbury, Victoria, Aus-
tralia) (basic medium [BM]). The tissue explants
were then plated 6well in a 12-well tissue culture
plate (Becton Dickinson Labware, Lincoln Park, NJ,
USA) coated with a thin layer of Matrigel (Collabora-
tive Research, Bedford, MA, USA) in BM. Primary
cultures of dissociated murine DRG neurons were
prepared as described elsewhere . 17 Both isolated
DRG and dissociated DRG cells were incubated in
BM at 37℃ in humidified 5% CO295% atmospheric
air.
NEURAL PROGENITOR CELL AND PC12 CELL
CULTURE
CC-2599 normal human neural progenitor cells
(NPC) capable of differentiating into neurons and
glial cells including astrocytes and oligodendro-
cytes18 were purchased from Clonetics (San Diego,
CA, USA). NPC were cultured in exclusive serum-
free medium (NPMM) containing 0.2% human re-
combinant basic fibroblast growth factor, 0.2% human
recombinant epidermal growth factor, 2% neural sur-
vival factor, and 0.2% gentamicin and amphotericin-B
(Clonetics). Approximately 2.5 × 104 cellswell were
seeded onto a 24-well culture and placed in a 37℃ hu-
midified incubator with 5% CO2 for 10 days. Rat pheo-
chromocytoma PC12 cells purchased from American
Type Culture Collection (Tokyo, Japan) were main-
tained in RPMI 1640 medium as described else-
where.19 For proliferation and differentiation of PC12
cells, the cells were allowed to attach on the dishes
before replacing the medium with RPMI 1640 supple-
mented with 2% fetal horse serum, NGF (1, 10, and 20
ngmL) (Sigma), and epinastine at concentrations of
10−7―10−3 M.
NEURITE EXTENSION IN SENSORY NEURONAL
CULTURES
Culture plates were immediately supplemented with
NGF (1, 10, or 20 ngmL) and epinastine at final con-
centrations of 10−9―10−3 M dissolved in BM. On the
basis of our preliminary experiments, the percentage
of DRG with outgrowing neurites was analyzed at 24
h and the number of DRG neurites after starting cul-
ture at 72 h . Twenty-four hours after exposure to
epinastine, all DRG in culture were observed under a
phase-contrast microscope (Nikon LWD 0.52, Tokyo,
Japan) to assess neurite outgrowth from DRG. Proc-
esses longer than the explant diameter were scored
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as positive. The number of neurites outgrowing from
DRG was recorded by actual counting under a phase-
contrast microscope 72 h after starting culture. To ex-
amine the effect of epinastine on extension length of
neurites, DRG were cultured in BM with NGF for 12
h prior to treatment with the tested drug. Each cul-
ture well was then supplemented with 10−9―10−3 M
epinastine into the culture medium. Phase-contrast
photomicrographs of the whole area of each culture
well were taken at 12-h intervals up to 72 h after start-
ing culture . The total length of each neurite was
measured with a computer-aided image analyzer sys-
tem as described elsewhere.20 Finally, the combined
length and the number of neurites were calculated
and divided by the number of DRG with neurites to
yield the average extension length of neurites12 h
and the neurite numberDRG, respectively.
EFFECT OF EPINASTINE ON NEURITE EXTEN-
SION IN NPC AND PC12 CELLS
Various concentrations of epinastine (10−7―10−1 M)
were supplemented with NPC during culture for <10
days. The total number of neurospheroid colonies
well and morphology of neurospheres were compara-
tively evaluated in the presence versus the absence of
epinastine . PC12 cells exposed to epinastine were
visualized by phase-contrast microscope (×100 magni-
fication). For quantification of neurite outgrowth, 
100 single cells (not aggregated)each area of 10 ar-
bitrary positions on the dish were observed , and
those with processes of length greater than the cell’s
diameter were counted as positive process-bearing
cells. For the cell proliferation assay, cultured PC12
cells were detached by incubation for 5 min in 0.05%
trypsin0.02% EDTA , and the cell number was
counted by a hematocytometer.
ASSESSMENT OF VIABILITY OF DRG CELLS
DRG cells were cultured in BM containing NGF and
epinastine for 72 h, removed by trypsin, and the cell
number was counted by a hematocytometer. To de-
termine the effects of epinastine on DRG neuron sur-
vival, trypan blue exclusion was used as described
previously.21
ENZYME-LINKED IMMUNOSORBENT ASSAY
FOR NGF
NGF levels were measured in BM with or without
epinastine by a highly sensitive, 2-site, immunoenzy-
matic assay as described elsewhere.11 All procedures
were performed using a commercial ELISA kit for
NGF following a modification of the protocol de-
scribed by Boehringer Mannheim (Germany). Sam-
ples composed of BM with NGF ( 10, 100, and
500 pgmL) and epinastine (10−7―10−3 M) and stan-
dard solutions (0―1000 pgmL) were used in the ex-
periment.
INDIRECT IMMUNOFLUORESCENCE
Dissociated DRG cells were cultured in BM with
NGF and 10−7―10−3 M epinastine for 72 h. Cells were
harvested by 2 min incubation with 0.05% trypsin
0.02% EDTA and cell suspensions fixed with 2% para-
formaldehyde solution . Cells were incubated with
monoclonal antibody directed against p 75 NGF-
receptor (NGF-R) (1:50) (Upstate Biotechnology Inc.,
NY, USA) and polyclonal antibody against p140 trk
NGF-R (1:50) (Santa Cruz Biotechnology, CA, USA)
for 1 h at 37℃ . Cells were then stained with
phycoerythrin-conjugated anti-rabbit IgG1 (Southern
Biotechnology Associates, Birmingham, AL, USA) for
20 min on ice . Cells were resuspended in cold
phosphate-buffered saline and analyzed by flow cy-
tometer (FACScan, Beckman Coulter KK, Tokyo, Ja-
pan). Mean fluorescence intensity5000 DRG cells
was measured electrically.
EFFECT OF EPINASTINE ON CAPSAICIN-
INDUCED SP RELEASE FROM SENSORY NEU-
RONS
DRG were cultured for 72 h in BM containing 10 ng
mL NGF and maintained in BM with 10−7―10−4 M
epinastine . Six hours later , capsaicin ( 1, 10, or
100 ngmL) (Sigma) was added to the culture me-
dium. Supernatants were then collected and supple-
mented with 5% (vv) protease inhibitor (Wako Pure
Chemical Industries, Ltd., Osaka, Japan) to protect
spontaneous degradation of SP. For determination of
SP levels, highly specific radioimmunoassay for SP
was performed, essentially as described previously.11
To identify sensory neurons , cultured specimens
were incubated with a primary polyclonal antibody
against SP ( Progen Immuno-Diagnostika , Heidel-
berg, Germany), a specific marker for DRG neurons,
at a dilution of 1:200. Immunohistochemistry was per-
formed by enhanced labeled polymer system (Dako,
Kyoto , Japan ) as described elsewhere . 22 Cultured
DRG neurons treated with epinastine were stained
before and after exposure to capsaicin.
RESULTS
EFFECTS ON SENSORY NEURONAL GROWTH
Representative DRG neurons with outgrowing neu-
rite processes in the absence and the presence of
epinastine are shown in Figure 1. Less than 5% of
DRG maintained in BM alone displayed neurite out-
growth, whereas 24 h after stimulation with 1, 10, and
20 ngmL NGF, more than 70% , 80% , and 90% of
DRG, respectively , exhibited outgrowing neurites .
Twenty-four hours after exposure to epinastine , a
clear concentration-dependent decrease in the per-
centage of DRG with outgrowing neurites was ob-
served at 10−7 M epinastine (Fig. 2). The number
of neurites from DRG was also significantly de-
creased by 10−7 M epinastine in a concentration-
dependent manner (Fig. 3). The total length of neu-
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Fig. 1 Representative DRG neurons with outgrowing neu-
rite processes (arows) in the absence (A) and presence (B) 
of epinastine. DRG neurons of ICR mice were cultivated in 
BM containing 10 ng/mL NGF w/wo the addition of 10－6 M 
epinastine for 72 h. Note numerous neurites branching from 
DRG neurons in (A), which are greatly reduced in (B) by epi-
nastine treatment. Original magnification,×250.
A
B
Fig. 2 Percentage of NGF-stimulated DRG with outgrow-
ing neurites after 24-h exposure to epinastine at various 
concentrations. *P＜0.05
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rites from DRG 72 h after starting culture signifi-
cantly decreased by 10−6 M epinastine in BM with
1 and 10 ngmL NGF and by 10−5 M epinastine in
BM with 20 ngmL of NGF (Fig. 4). While the aver-
age extension length of neurites12 h without epinas-
tine was relatively constant , epinastine suppressed
the extension rates in a time-dependent fashion, start-
ing from 12―24 h after supplementation, regardless of
NGF concentration (Fig. 5).
NEUROTOXIC EFFECTS
The percentage of“dead”(i.e., trypan blue-stained)
DRG cells remained unchanged in all concentrations
of epinastine added, ranging from 0.7―2% (data not
shown). Furthermore, there was no significant differ-
ence in the percentage of viable cells in the absence
versus the presence of epinastine.
NGF LEVELS
NGF levels measured by ELISA persisted unchanged
and no significant differences in NGF levels were
found in the absence versus the presence of epinas-
tine (data not shown).
INFLUENCE ON NEUROTROPHIC EFFECTS OF
NGF ON PC12 CELLS
While PC12 cells neither proliferated nor extended
neurite processes in the absence of NGF, cells bear-
ing processes were observed in the presence of NGF.
When increasing concentrations of epinastine from
10−7―10−3 M were added to PC12 cells cultured with
NGF, no effects were observed in neurite extension,
determined either by the percentage of process-
bearing cells, or by the number of proliferating cells
(data not shown).
EFFECTS ON NGF-R EXPRESSION
DRG cells expressed both p75 and p140 NGF-R .
When DRG cells were exposed to epinastine 10− 7
―10−3 M, no significant difference in mean fluores-
cence intensity of either type NGF-R was observed at
any concentration added (data not shown).
TOXICITY ON CENTRAL NERVOUS SYSTEM
NPC
No visible morphological differences in neurosphe-
roid formation and neurite extension were observed
in the absence versus the presence of epinastine even
at high concentrations. Furthermore, no significant
difference in the number of colonies extending neu-
rite processes was seen at any concentration of
epinastine10 days after culture starting from single
cell suspensions (Fig. 6).
EFFECT ON CAPSAICIN-INDUCED SP RELEASE
FROM DRG NEURONS
Baseline levels of SP released by capsaicin increased
in a concentration-dependent manner . Epinas-
tine 10−5 M suppressed SP levels in supernatants
568 Allergology International Vol 54, No4, 2005 www.jsaweb.jp
Toyoda M et al.
Fig. 3 Number of neurites from NGF-stimulated DRG after 
exposure to epinastine at various concentrations for 72 h. *P
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Fig. 4 Total length of neurites from NGF-stimulated DRG 
after exposure to epinastine at various concentrations for 72 
h. *P＜0.05
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Fig. 5 Average extension length of NGF-stimulated 
neurites/12 h after addition of epinastine. *P＜0.05
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after DRG neurons were exposed to capsaicin 1, 10,
and 100 ngmL in a concentration-dependent manner
(Fig. 7). Cultured DRG neurons and extending nerve
fibers showed intense immunoreactivity with SP ,
which diminished after exposure to capsaicin; how-
ever , epinastine-treated neurons remained positive
for SP (data not shown).
DISCUSSION
The current study was conducted to determine
whether epinastine has any direct influence on sen-
sory neurons. Altered patterns of cutaneous innerva-
tion have been reported in many inflammatory der-
matoses including atopic dermatitis 9,10 and psoria-
sis.22,23 One major symptom of these skin disorders is
pruritus, where sensory C fibers are stimulated both
in the epidermis and in the superficial dermis. It has
been reported that the epidermis and dermis of le-
sional skin from patients with atopic dermatitis and
psoriasis with pruritus are significantly more densely
innervated with nerve fibers than either lesion-free
skin or normal healthy skin9,23 suggesting that pa-
tients with these pruritic skin disorders may be more
vulnerable to intrinsic and extrinsic stimuli following
stimulation of C fibers and that hyperinnervation in
the skin of patients with pruritus may result in a
lower itch threshold compared with in those without
pruritus. In the present study, we observed epinas-
tine concentration-dependent decreases in the per-
centage of DRG with outgrowing neurites, number of
neuritesDRG, and average neurite extension length,
indicative of novel anti-pruritic modes of action of
epinastine. The concentrations of epinastine exerting
inhibitory action on sensory neurons in the present
study correspond roughly to those found in the blood
in vivo after oral administration of the drug.24 How-
ever, it is not yet certain whether such neuromodula-
tory effects are specific to epinastine among antihista-
mines. This will be the subject of further study.
NGF is the most fully characterized neurotrophic
protein responsible for the development, differentia-
tion, and survival of peripheral neurons. NGF guides
neuritic growth in the periphery, thereby serving a
trophic function,25 which suggests that innervation in
the skin resulting from neurite extension from DRG
neurons may be modulated by NGF. NGF is trans-
ported in a retrograde fashion from target tissues and
nerve terminals to neuronal cell bodies and exerts
neurotrophic effects on some primary neural crest-
derived sensory neurons and peripheral adrenergic
and central cholinergic neurons.26 Although the pre-
cise mechanism of epinastine’s suppressive activity
on sensory neurons is not clear, there remains the
possibility that epinastine has direct neurotoxic ef-
fects on sensory neurons . Short-term exposure to
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Fig. 6 Representative neurospheroids (asterisks) extend-
ing neurite processes (arows) in the absence (A) and pres-
ence (B) of epinastine. Normal human neural progenitor 
cels were cultivated in the culture medium w/wo the addi-
tion of 10－3 M epinastine for 10 days. No visible morphologi-
cal diferences in neurospheroid formation and neurite 
extension were seen between (A) and (B). Original magnifi-
cation, ×420.
A
B
Fig. 7 Efect of various concentrations of epinastine on 
SP levels in supernatants after exposing DRG neurons to 
capsaicin. *P＜0.05; †P＜0.01
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some drugs such as lidocaine, a local anesthetic, has
been reported to induce death in cultured DRG neu-
rons in vitro.27 Therefore we performed the present
trypan blue exclusion experiments in dissociated
DRG cells to observe cell viability after exposure to
various concentrations of epinastine. As a result, the
percentage of trypan blue-stained DRG cells re-
mained unchanged at any concentration of epinastine
added, and there was no statistically significant differ-
ence in the percentage of viable cells in the absence
versus the presence of epinastine , suggesting that
epinastine has no neurotoxicity. Another possibility
regarding epinastine’s inhibitory mechanism on sen-
sory neurons is rapid degradation andor inactivation
of NGF. We measured NGF levels in BM containing
low concentrations of exogenous NGF treated with
epinastine by ELISA, and observed neurotrophic ef-
fects of NGF-containing medium supplemented with
epinastine on rat pheochromocytoma PC 12 cells .
This approach was based on many previous studies
on the intracellular signaling cascades for neurite out-
growth triggered by NGF which were performed in
this cell line.28 NGF levels in medium persisted un-
changed after addition of epinastine and no signifi-
cant differences in NGF levels were observed in the
absence versus the presence of epinastine, suggest-
ing that epinastine is unable to degrade NGF. Differ-
entiation evaluated by the percentage of neurite
process-bearing cells and proliferation measured by
the number of PC 12 cells were uninfluenced by
epinastine, further implying that epinastine may not
inactivate NGF.
NGF exerts its effects by binding two classes of
transmembrane receptors, a low affinity receptor ~ 75
kd (p75) and a high affinity receptor ~ 140 kd (trk A).
While it has been demonstrated that expression of
the trk A protooncogene is critical for NGF signal
transduction in primary neurons,29 much uncertainty
exists concerning the functional role of the p75 recep-
tor component . Both NGF-R subtypes have been
identified on sensory nerves . 30 Increased levels of
both p75 and trk A NGF-R mRNA have been demon-
strated in DRG of rat following nerve injury.31 How-
ever , recent studies have shown that high-affinity
binding of NGF to PC12 cells requires both the p75
and trk A NGF-R and that the relative numbers of
each receptor determines the NGF binding affinity.32
Since the functional relationship between these NGF-
R is still in dispute, we examined the effects of epinas-
tine on both p75 and trk A NGF-R expression in DRG
cells in culture by flow cytometry. No significant dif-
ferences were found in mean fluorescence intensity
of both p75 and trk A NGF-R at any epinastine con-
centration tested, indicating that the inhibitory activi-
ties of epinastine on sensory neurons may not be me-
diated by NGF-R. Hence the cellular mechanism for
the suppressive effects of epinastine on sensory neu-
rons remains unexplained.
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We demonstrated that the central nervous system
is uninfluenced by epinastine even when high con-
centrations of epinastine were added to cultured
NPC. This may be extremely important because it be-
came evident from our experiments that epinastine is
not neurotoxic to multipotential progenitor cells in
the central nervous system, suggesting that its inhibi-
tory effects on neurons are specific against the pe-
ripheral nervous system. Taking into account epinas-
tine’s low penetration of the blood-brain barrier,33 its
effects on the central nervous system appear negligi-
ble. The underlying reason for the observed differ-
ences in response to epinastine observed in the pe-
ripheral and central nervous systems is not clear. Al-
though NGF and NGF-R are localized to diverse brain
areas and active glial growth is associated with ex-
pression of the NGF gene,34 NGF’s function during
normal development and maturity remains to be elu-
cidated. The expression of NGF by brain astrocytes is
considered analogous to that of peripheral Schwann
cells. While cultured Schwann cells contain high lev-
els of NGF, the message is virtually undetectable in
adult peripheral glia.35 The sciatic nerve, which con-
sists mostly of Schwann cells, expresses high levels
of NGF mRNA at birth, with rapid decreases in ex-
pression during development. The NGF message is
extremely low in the adult sciatic nerve . 36 We ob-
served cultured NPC rapidly proliferating and differ-
entiating into neural components of the central nerv-
ous system. Taken together, different contents of lo-
cally accumulated NGF derived from neuron-
supporting cells may be associated with different re-
sponses of neurons to epinastine, via neuroprotective
activity of NGF, between the central and peripheral
nervous systems.
SP is associated with multiple cellular responses in-
cluding vasodilatation, increased blood flow, plasma
extravasation, mast cell degranulation, the wheal and
flare reaction via axon reflex referred to as neuro-
genic inflammation, neutrophil and macrophage acti-
vation, and modulation of the release of proinflamma-
tory cytokines and chemokines.7 Neurogenic inflam-
mation is mediated by SP released from peripheral
sensory nerve terminals , which in turn stimulates
specific receptors on and releases histamine from
mast cells ; the released histamine then further ex-
cites other sensory neurons . When applied to the
skin, SP elicits an itch sensation in human subjects.37
SP is generally believed to elicit pruritus through the
release of histamine from mast cells. In human sub-
jects , H1-receptor antagonists inhibit itch sensation
induced by intradermal injection of low-dose SP.37 In-
tradermal injection of SP elicits itch-associated re-
sponse in normal as well as in mast cell-deficient
mice . 38 Neurokinin-1 tachykinin receptors are in-
volved in the itch-associated response induced by SP,
but not in histamine release from mast cells.38 These
findings suggest that both mast cell-dependent and
independent mechanisms are involved in SP-induced
itch-associated response.7 It is known that capsaicin
enhances release of SP from sensory neurons and
nerve terminals in both the central and peripheral
nervous systems and induces tachyphylaxis after re-
peated application.39 In the present study we demon-
strate that capsaicin-induced SP release from cul-
tured DRG neurons is inhibited by epinastine in a
concentration-dependent manner. The immunohisto-
chemical study, in which diminution of immunoreac-
tivity of cultured DRG neurons and extending nerve
fibers exposed to capsaicin was suppressed by pre-
treatment with epinastine, supports the assay experi-
ment . Such inhibitory effects of epinastine on
capsaicin-induced SP release from sensory neurons
may , in part , explain epinastine’s clinical efficacy
against inflammatory pruritic skin diseases.
In conclusion, here we demonstrate for the first
time that epinastine possesses pharmacological
modes of action on cutaneous sensory neurons in-
cluding suppressive effects on neurite extension and
inhibitory effects on SP release. These functions may
in turn contribute to the drug’s potent clinical efficacy
and marked relief of itch intensity in pruritic dermato-
ses such as atopic dermatitis. Better understanding of
the mechanisms of these effects on sensory neurons
should aid in the development of pharmacological
strategies to establish effective usage of the drug
against allergic skin diseases with pruritus. Further
studies are necessary to examine the effect of other
firstsecond-generation antihistamines to clarify
whether this effect is specific for epinastine.
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